Interesting to read, yes. But as a company, I didn't read it on the screen. I tend to be with the big global players when it comes to biotech and health. For me, the risk with the small companies is just too big. Morphosys has also made some strange decisions on the part of management in the past, after all. I don't need any turmoil in that respect, but thank you for the introduction.
•
11
•
@InvestmentPapa Interesting! I didn't read about the management during my research. Thanks for the addition 👍 I'm also rather distanced!
••